Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Breast Neoplasms × Alginates × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

Tamoxifen 9 Docetaxel 8 Trastuzumab 7 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Exercise 6 Indocyanine Green 5 Cyclophosphamide 5 Control Groups 5 Carboplatin 5 pertuzumab 4 exemestane 4 Doxorubicin 4 Capecitabine 4 Anastrozole 4 dalpiciclib 3 Vinorelbine 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Cisplatin 3 pyrotinib 2 ferumoxides 2 Zoledronic Acid 2 Tablets 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡